| 1 |
Rationale and design of REDUCE‐IT : Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial
Deepak L. Bhatt, Philippe Gabríel Steg, Eliot A. Brinton et al. · Clinical Cardiology
Open access |
Mar 2017 |
183 |
| 2 |
Increased residual cardiovascular risk in patients with diabetes and high versus normal triglycerides despite statin‐controlled LDL cholesterol
Gregory A. Nichols, Sephy Philip, Kristi Reynolds et al. · Diabetes Obesity and Metabolism
Open access |
18 Sep 2018 |
127 |
| 3 |
High Triglycerides Are Associated With Increased Cardiovascular Events, Medical Costs, and Resource Use: A Real‐World Administrative Claims Analysis of Statin‐Treated Patients With High Residual Cardiovascular Risk
Peter Paul Toth, Craig B. Granowitz, MICHAEL L. HULL et al. · Journal of the American Heart Association
Open access |
7 Aug 2018 |
121 |
| 4 |
Real-time on-line blend uniformity monitoring using near-infrared reflectance spectrometry: A noninvasive off-line calibration approach
Yusuf Sulub, Busolo Wabuyele, Paul Gargiulo et al. · Journal of Pharmaceutical and Biomedical Analysis
|
15 Oct 2008 |
77 |
| 5 |
Pharmacokinetics of eicosapentaenoic acid in plasma and red blood cells after multiple oral dosing with icosapent ethyl in healthy subjects
Rene A. Braeckman, William G. Stirtan, Paresh N. Soni · Clinical Pharmacology in Drug Development
Open access |
11 Oct 2013 |
55 |
| 6 |
Analgesic and adverse effects of a fixed-ratio morphine-oxycodone combination (MoxDuo®) in the treatment of postoperative pain
Patricia T. Richards, Dennis Riff, R. Kelen et al. · Journal of Opioid Management
|
26 Jul 2011 |
35 |
| 7 |
Elevated Triglycerides (≥150 mg/dL) and High Triglycerides (200–499 mg/dL) Are Significant Predictors of Hospitalization for New-Onset Kidney Disease: A Real-World Analysis of High-Risk Statin-Treated Patients
Peter Paul Toth, Sephy Philip, MICHAEL L. HULL et al. · Cardiorenal Medicine
Open access |
2019 |
22 |
| 8 |
Comparison of the Efficacy and Safety of Dual-Opioid Treatment With Morphine Plus Oxycodone Versus Oxycodone/Acetaminophen for Moderate to Severe Acute Pain After Total Knee Arthroplasty
Patricia T. Richards, Joseph S Gimbel, Harold S. Minkowitz et al. · Clinical Therapeutics
|
29 Mar 2013 |
19 |
| 9 |
A Phase 3, Randomized, Double-Blind Comparison of Analgesic Efficacy and Tolerability of Q8003 vs Oxycodone or Morphine for Moderate-to-Severe Postoperative Pain Following Bunionectomy Surgery
Patricia T. Richards, Dennis Riff, R. Kelen et al. · Pain Medicine
Open access |
26 Jun 2013 |
19 |
| 10 |
Hypertriglyceridemia is associated with an increased risk of peripheral arterial revascularization in high‐risk statin‐treated patients: A large administrative retrospective analysis
Peter Paul Toth, Sephy Philip, MICHAEL L. HULL et al. · Clinical Cardiology
Open access |
Aug 2019 |
15 |
| 11 |
Analgesic Efficacy and Tolerability of Intravenous Morphine Versus Combined Intravenous Morphine and Oxycodone in a 2-Center, Randomized, Double-Blind, Pilot Trial of Patients With Moderate to Severe Pain After Total Hip Replacement
Robin Joppich, Patricia T. Richards, R. Kelen et al. · Clinical Therapeutics
|
15 Jul 2012 |
15 |
| 12 |
Evaluation of Transmission and Reflection Modalities for Measuring Content Uniformity of Pharmaceutical Tablets with Near-Infrared Spectroscopy
Dong Xiang, Rosario LoBrutto, James Cheney et al. · Applied Spectroscopy
|
2009 |
15 |
| 13 |
Lipid Effects of Icosapent Ethyl in Women with Diabetes Mellitus and Persistent High Triglycerides on Statin Treatment: ANCHOR Trial Subanalysis
Eliot A. Brinton, Christie Mitchell Ballantyne, John R. Guyton et al. · Journal of Women s Health
Open access |
27 Mar 2018 |
13 |
| 14 |
Improving Lipids With Prescription Icosapent Ethyl After Previous Use of Fish Oil Dietary Supplements
Kota J. Reddy, Sumita Chowdhury · Future Cardiology
Open access |
12 Apr 2016 |
5 |
| 15 |
Co‐administration of oxycodone and morphine and analgesic synergy re‐examined
Maree T. Smith, Felix A. de la Iglesia · British Journal of Clinical Pharmacology
Open access |
30 Mar 2005 |
5 |
| 16 |
Comparison of analgesic response and safety of flexible dose vs fixed low dose MoxDuo® IR (morphine plus oxycodone) in patients with moderate to severe pain following total knee arthroplasty
Patricia T. Richards, R. Kelen, Harold S. Minkowitz et al. · Journal of Pain
Open access |
Apr 2011 |
2 |
| 17 |
Comparative effects of MoxDuo® (morphine plus oxycodone) relative to morphine alone or oxycodone alone on respiratory depression in a post-surgical setting
Patricia T. Richards, W. Eugene Stern, R. Kelen et al. · Journal of Pain
Open access |
Apr 2011 |
1 |
| 18 |
Clinical importance of moderate to severe adverse events experienced during opioid management of acute pain
Patricia T. Richards, R. Kelen, Meagan E. Spychala et al. · Journal of Pain
Open access |
Apr 2011 |
1 |
| 19 |
Evaluation of current practices and communication surrounding sudden unexpected death in epilepsy ( SUDEP ): A survey analysis of healthcare practitioners
Katherine C. Nickels, Carly Katterman, Kelly Gwin et al. · Epilepsia Open
Open access |
2 Sep 2026 |
0 |
| 20 |
Tolerability of sublingual versus vestibular allergy immunotherapy tablet administration: A randomized pilot study
Marie‐Lee Simard, Natalija Novak, Jean‐Philippe Drolet et al. · Clinical & Experimental Allergy
Open access |
21 Nov 2023 |
0 |
| 21 |
Rationale and development of an algorithm for conversion from IV PCA to MoxDuo® in acute postoperative pain
Patricia T. Richards, W. Eugene Stern · Journal of Pain
Open access |
Apr 2012 |
0 |
| 22 |
H6.2. Dual-Opioids™ (morphine+oxycodon) provide analgesia with reduced side effects in acute surgical pain
John W. Holaday, Patricia T. Richards · Perioperative Medizin
|
31 Oct 2009 |
0 |
| 23 |
Comparison of analgesic response and safety of intravenous morphine vs intravenous morphine and oxycodone in a 1:1 ratio in patients with moderate to severe pain following total hip replacement
Patricia T. Richards, R. Kelen, W. Eugene Stern et al. · Journal of Pain
Open access |
Apr 2011 |
0 |